Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Atri Cure, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$19.65 - $30.28 $5.51 Million - $8.5 Million	-280,620 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $4.22 Million - $5.9 Million	280,620 New	280,620 $5.76 Million

Others Institutions Holding ATRC

# of Institutions

215

Shares Held

49.8M

Call Options Held

12K

Put Options Held

7.2K

Vanguard Group Inc Valley Forge, PA

4.66M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$189 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

3.97M
Shares

$163 Million
0.04% of portfolio
Hood River Capital Management LLC Palm Beach Gardens, FL

2.83M
Shares

$116 Million
1.47% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.79M
Shares

$114 Million
0.5% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.9B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account